Smith Group Asset Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Smith Group Asset Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-13,080	Closed	-$52K	–	471
2017 Q3	$52K	Sell	13,080 -950	-7%	-$4.36K	﹤0.01%	313
2017 Q2	$72K	Sell	14,030 -6,400	-31%	-$35.9K	﹤0.01%	304
2017 Q1	$141K	Buy	+20,430	New	+$160K	﹤0.01%	289
2016 Q4	–	Sell	-25,720	Closed	-$252K	–	494
2016 Q3	$252K	Buy	25,720 +520	+2%	+$7.01K	0.01%	226
2016 Q2	$356K	Buy	25,200 +18,780	+293%	+$293K	0.01%	206
2016 Q1	$90K	Buy	+6,420	New	+$94.2K	﹤0.01%	277
2015 Q2	–	Sell	-49,590	Closed	-$991K	–	440
2015 Q1	$991K	Buy	+49,590	New	+$1.11M	0.03%	175

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

MERSOM

Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return

Smith Group Asset Management's AGTC Position: Q4 2017 in Review

Smith Group Asset Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2017, closing a stake of 13,080 shares — an estimated $52K sold.

Smith Group Asset Management first reported a position in AGTC in Q1 2015 and held it in 7 quarters. The position peaked at $991K in Q1 2015. 62 funds tracked by Wall St. Rank hold AGTC as of Q4 2017.

Smith Group Asset Management reported no remaining Applied Genetic Technologies Corporation position as of Q4 2017 after selling out during the quarter.
Smith Group Asset Management sold 13,080 Applied Genetic Technologies Corporation shares in Q4 2017, an estimated $52K.
Smith Group Asset Management first reported a position in Applied Genetic Technologies Corporation in Q1 2015 and held it in 7 quarters.
Smith Group Asset Management's Applied Genetic Technologies Corporation position peaked at $991K in Q1 2015.
62 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2017.

Based on Smith Group Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.